Verona Pharma plc (VRNA) Tops Q4 EPS by 1c

Verona Pharma plc (NASDAQ: VRNA) reported Q4 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03).

For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AeroVironment restates quarterly financials, citing $89M goodwill error
• RBC Capital Starts Molina Healthcare (MOH) at Sector Perform